(S1 (S (NP (NP (NN Role)) (PP (IN of) (NP (NN glycogen) (NN synthase) (NN kinase-3))) (PP (IN in) (NP (NP (NP (JJ TNF-alpha-induced) (NN NF-kappaB) (NN activation)) (CC and) (NP (NN apoptosis))) (PP (IN in) (NP (NNS hepatocytes))))) (. .))))
(S1 (S (S (NP (NP (JJ Nuclear) (NN factor-kappaB)) (PRN (-LRB- -LRB-) (NP (NN NF-kappaB)) (-RRB- -RRB-))) (VP (VBZ prevents) (NP (NNS hepatocytes)) (PP (IN from) (S (VP (VBG undergoing) (NP (NN apoptosis)) (PP (IN during) (NP (NP (NN development)) (CC and) (NP (NN liver) (NN regeneration))))))))) (. .)))
(S1 (S (S (NP (NP (NNS Mice)) (PP (IN with) (NP (VBN inactivated) (NP (NP (JJ glycogen) (NN synthase) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN GSK)) (-RRB- -RRB-))) (NN -3beta)))) (VP (VBP die) (PP (IN from) (NP (NN hepatocyte) (NN apoptosis))) (PP (IN during) (NP (NP (NN development)) (ADJP (JJ due) (PP (TO to) (NP (NP (DT a) (NN defect)) (PP (IN in) (NP (NN NF-kappaB) (NN activation)))))))) (PRN (-LRB- -LRB-) (NP (NP (NP (NNP Hoeflich) (NNP KP) (, ,) (NNP Luo) (NNP J) (, ,) (NNP Rubie)) (NP (NN EA))) (, ,) (NP (NP (NNP Tsao) (NN MS)) (, ,) (NP (NNP Jin) (NN O)) (, ,) (CC and) (NP (NP (NN Woodgett)) (NP (NP (NNP JR.) (NNP Nature) (CD 406) (: :) (CD 86-90)) (, ,) (NP (CD 2000)))))) (-RRB- -RRB-)))) (. .)))
(S1 (S (S (PP (IN In) (NP (DT this) (NN study))) (, ,) (NP (PRP we)) (VP (VBD determined) (NP (NP (DT the) (NN role)) (PP (IN of) (NP (NN GSK-3))) (PP (IN in) (NP (NP (NP (JJ TNF-alpha-induced) (NN NF-kappaB) (NN activation)) (CC and) (NP (NN cell) (NN death))) (PP (IN in) (NP (JJ primary) (NNS hepatocytes)))))))) (. .)))
(S1 (S (S (NP (NP (NN LiCl)) (, ,) (NP (NP (DT an) (JJ established) (NN inhibitor)) (PP (IN of) (NP (NN GSK-3)))) (, ,)) (VP (VBN sensitized) (NP (JJ primary) (NN rat) (NNS hepatocytes)) (PP (IN toward) (NP (NP (JJ TNF-alpha-mediated) (NN apoptosis)) (VP (VBG resulting) (PP (IN in) (NP (ADJP (CD 90) (NN %)) (NN cell) (NN death))) (PP (IN after) (NP (CD 24) (NN h)))))))) (. .)))
(S1 (S (S (NP (DT This)) (VP (VBD was) (VP (VBN accompanied) (PP (IN by) (NP (NP (VBN increased) (NN caspase) (ADJP (ADJP (JJ 8-like)) (CC and) (ADJP (JJ 3-like))) (NNS activities)) (, ,) (NP (JJ nuclear) (NN fragmentation)) (CC and) (NP (NN DNA) (NN laddering))))))) (. .)))
(S1 (S (S (NP (NN LiCl) (NN treatment)) (VP (VP (VBD had) (NP (DT no) (NN effect)) (PP (IN on) (NP (NP (NN IkappaB-alpha) (NN degradation)) (, ,) (NP (NP (NP (NN IkappaB) (NN kinase)) (PRN (-LRB- -LRB-) (NP (NN IKK)) (-RRB- -RRB-))) (NN activity)) (, ,) (NP (NN NF-kappaB) (NN binding) (NN activity)) (, ,) (CC and) (NP (NP (NN p65) (JJ nuclear) (NN import)) (CC and) (NP (NN export)))))) (, ,) (CC but) (VP (VBD decreased) (NP (NP (NN transcription)) (PP (IN of) (NP (NP (NP (DT the) (JJ NF-kappaB-dependent) (JJ inducible) (JJ nitric) (NN oxide) (NN synthase)) (NN gene)) (CC and) (NP (DT a) (JJ NF-kappaB-driven) (NN reporter) (NN gene)))))))) (. .)))
(S1 (S (S (NP (DT The) (NN p65) (NN sequence)) (VP (VBD revealed) (NP (NP (NP (CD four) (JJ potential) (NN GSK-3) (NN phosphorylation) (NNS sites)) (PP (IN within) (NP (NP (PRP$ its) (JJ COOH-terminal) (NN transactivation) (NNS domains)) (CC and) (NP (NP (NP (JJ recombinant) (NN GSK-3beta) (JJ phosphorylated) (NN glutathione) (NN S-transferase)) (PRN (-LRB- -LRB-) (NP (NN GST)) (-RRB- -RRB-))) (NN -p65-LRB-354-551-RRB-))))) (, ,) (CONJP (CC but) (RB not)) (NP (NN GST-p65-LRB-1-305-RRB-))) (ADVP (FW in) (FW vitro)))) (. .)))
(S1 (S (S (NP (DT These) (NNS results)) (VP (VBP indicate) (SBAR (IN that) (S (NP (NN GSK-3)) (VP (VBZ protects) (NP (NNS hepatocytes)) (PP (IN from) (NP (JJ TNF-alpha-induced) (NN apoptosis))) (PP (IN through) (NP (NP (NN p65) (NN phosphorylation)) (CC and) (NP (NP (NN upregulation)) (PP (IN of) (NP (NN NF-kappaB) (NN transactivation))))))))))) (. .)))
